HomeInsightsResults

Shukra Pharmaceuticals Ltd Quarterly Result

Shukra Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

8.8 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

Net Profit

₹ 0.54

Last updated on: Nov 25, 2024

Key Highlights

  • The revenue of Shukra Pharmaceuticals Ltd for the Sep '24 is ₹ 6.57 crore as compare to the Jun '24 revenue of ₹ 3.9 crore. This represent the growth of 68.46154%.
  • The ebitda of Shukra Pharmaceuticals Ltd for the Sep '24 is ₹ 1.68 crore as compare to the Jun '24 ebitda of ₹ 1.52 crore. This represent the growth of 10.526314%.
  • The net profit of Shukra Pharmaceuticals Ltd for the Sep '24 is ₹ 0.54 crore as compare to the Jun '24 net profit of ₹ 0.49 crore. This represent the growth of 10.204083%.

Results Analysis

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202458.9
21 Nov 202458.28
19 Nov 202460.39
18 Nov 202462.68
14 Nov 202465.97
13 Nov 202464.93
12 Nov 202466.36
11 Nov 202469.15
08 Nov 202466.08
07 Nov 202467.87

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Shukra Pharmaceuticals Ltd News Hub

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

08 Nov 202417:22

News

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 ...

Read more

24 Sep 202410:28

News

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company...

Read more

16 Sep 202410:13

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

05 Aug 202410:57

News

Shukra Pharmaceuticals schedules EGM

Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

31 Jul 202417:47

News

Board of Shukra Pharmaceuticals recommends final dividend

Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

30 May 202412:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Shukra Pharmaceuticals Ltd Quarterly Result

What is the EPS of Shukra Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Shukra Pharmaceuticals Ltd is 3.3. An EPS is the amount of net income attributed to each share of a common stock.

How is Shukra Pharmaceuticals Ltd EPS calculated?

The EPS of Shukra Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Shukra Pharmaceuticals Ltd report its EPS?

Shukra Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Shukra Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Shukra Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Shukra Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Shukra Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*